摘要
背景:肺动脉高压是影响人类健康的慢性疾病之一。微囊泡通过与受体细胞融合,将脂质、蛋白质、RNA等生物活性分子转移到靶细胞中,参与细胞之间的通信。微囊泡参与多种生物过程,具有调节免疫、促进血管生成等功能。来自各种细胞的微囊泡可能成为该疾病的诊断生物标志物或治疗靶点。因此,探索微囊泡介导的细胞通信的作用已成为肺动脉高压的潜在治疗靶点。 目的:阐明微囊泡在细胞通信中的分类、特征和机制,并探讨微囊泡介导的细胞通信在肺动脉高压中潜在的重要作用。 结果:炎症是肺动脉高压的重要发病机制。许多研究表明,来自不同细胞的微泡可以通过转移肺动脉高压中包含的炎症因子来参与肺动脉高压的病理过程。 结论:微泡介导的细胞通讯可能成为肺动脉高压的治疗靶点
关键词: 微囊泡、细胞外囊泡、细胞通讯、巨噬细胞来源的微囊泡、肺动脉高压、炎症。
Current Medicinal Chemistry
Title:Microvesicles-mediated Cell Communication in Pulmonary Arterial Hypertension
Volume: 28 Issue: 23
关键词: 微囊泡、细胞外囊泡、细胞通讯、巨噬细胞来源的微囊泡、肺动脉高压、炎症。
摘要:
Background: Pulmonary arterial hypertension is one of the chronic diseases that affect human health. Microvesicles participate in the communication between cells by fusing with the recipient cells to transfer the bioactive molecules, such as lipids, proteins, RNA, etc., to the target cells. Microvesicles are involved in various biological processes and have the functions of regulating immunity, promoting angiogenesis, and so on. Microvesicles derived from various cells may become the diagnostic biomarkers or therapeutic targets for the diseases. Therefore, exploring the role of microvesicles-mediated cell communication has become a potential therapeutic target for pulmonary arterial hypertension.
Objective: It is to clarify the classification, features, and mechanism of microvesicles in cell communication and to discuss the potentially important roles of microvesicles-mediated cell communication in pulmonary arterial hypertension.
Results: Inflammation is an important pathogenesis of pulmonary arterial hypertension. Many studies have shown that microvesicles from different cells can participate in the pathological process of pulmonary arterial hypertension by transferring the inflammatory factors contained in them.
Conclusion: Microvesicles-mediated cell communication may become the therapeutic target for pulmonary arterial hypertension.
Export Options
About this article
Cite this article as:
Microvesicles-mediated Cell Communication in Pulmonary Arterial Hypertension, Current Medicinal Chemistry 2021; 28 (23) . https://dx.doi.org/10.2174/0929867328666201124152406
DOI https://dx.doi.org/10.2174/0929867328666201124152406 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and Biological Evaluation of Curcumin-Nitroxide-Based Molecular Hybrids as Antioxidant and Anti-Proliferative Agents
Medicinal Chemistry Mucoadhesive Microspheres Containing Anti-Hypertensive Agent: Formulation and Characterization
Current Drug Delivery Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Current Vascular Pharmacology Soluble Epoxide Hydrolase: A Novel Target for the Treatment of Hypertension
Recent Patents on Cardiovascular Drug Discovery Pharmacophoric Modeling and Atom-Based 3D-QSAR of Novel 1-Aryl-3-(1-acylpiperidin-4-yl) Urea as Human Soluble Epoxide Hydrolase Inhibitors (sEHIs)
Medicinal Chemistry Retracted: Potential Health Benefits of Broccoli- A Chemico-Biological Overview
Mini-Reviews in Medicinal Chemistry Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Editorial [Hot Topic: Food-Derived Bioactive Proteins and Peptides as Potential Components of Nutraceuticals (Executive Editor: H. Meisel)]
Current Pharmaceutical Design Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Editorial [Hot topic: Anti-Angiogenic Agents (Executive Editor: Maurizio Botta and Anna Di Donna)]
Current Pharmaceutical Design Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf
Current Vascular Pharmacology Impairment of Liver Glycogen Storage in the db/db Animal Model of Type 2 Diabetes: A Potential Target for Future Therapeutics?
Current Drug Targets Microalbuminuria In Primary Hypertension
Current Hypertension Reviews Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
Current Diabetes Reviews Impact of Jugular Vein Valve Function on Cerebral Venous Haemodynamics
Current Neurovascular Research Pharmacotherpy and Alzheimer’s Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach
Current Pharmaceutical Design Premature Adrenarche and its Association with Cardiovascular Risk in Females
Current Pharmaceutical Design Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
Current Diabetes Reviews Pleiotropic Effects of ARB in Diabetes Mellitus
Current Vascular Pharmacology